The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...

Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

Abu Dhabi's M42 is building one of the largest DNA databases, combining this with pharmacology and AI tools to create more ...

Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular ...

Shop the best early Black Friday and Cyber Monday deals from Sephora, including discounts on skin care, makeup, hair care, ...

NEW ORLEANS (WVUE) - Baton Rouge-based chart-topping rapper NBA YoungBoy, whose legal name is Kentrell Gaulden, pleaded guilty in Logan District Court on Monday (Nov. 18) to charges connected to a ...

The accused killers, 24-year-old Mike Vladislav Kruglik of West Bloomfield and 26-year-old Jesse Del Jordan Bradshaw of New ...

Weight-loss drugs promise to make the pounds melt away, and beauty products and fillers will erase those fine lines. But do you know what you're getting or where it's coming from?

Amaury Abreu, 38, an 11-year NYPD veteran, had a secret life as the close confidant to the leader of a drug ring that ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

When Democrats rammed through the Inflation Reduction Act during the days they controlled all of Washington, D.C., it ignited ...